| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
149,570 |
112,893 |
$16.25M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
73,448 |
63,784 |
$15.70M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
72,316 |
64,638 |
$15.58M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
61,392 |
55,595 |
$14.25M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
27,064 |
21,449 |
$14.02M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
56,675 |
50,138 |
$11.08M |
| 99215 |
Prolong outpt/office vis |
55,816 |
48,444 |
$10.83M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
47,184 |
42,734 |
$9.38M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
48,508 |
37,892 |
$8.58M |
| J9271 |
Injection, pembrolizumab, 1 mg |
1,112 |
799 |
$7.99M |
| 70450 |
Computed tomography, head or brain; without contrast material |
18,968 |
17,455 |
$4.70M |
| 59025 |
Fetal non-stress test |
13,750 |
7,626 |
$4.48M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
4,766 |
4,465 |
$3.41M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
8,616 |
7,859 |
$3.34M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
12,712 |
11,320 |
$3.03M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
17,145 |
15,190 |
$3.02M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
13,962 |
13,008 |
$2.86M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
9,360 |
8,455 |
$2.53M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
13,464 |
12,279 |
$2.34M |
| 77412 |
|
7,816 |
755 |
$2.32M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12,978 |
11,819 |
$2.32M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
3,795 |
3,588 |
$2.22M |
| 20610 |
|
5,786 |
5,269 |
$2.16M |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
2,541 |
2,403 |
$2.14M |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
1,998 |
1,770 |
$1.98M |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
1,958 |
1,871 |
$1.89M |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
1,579 |
1,349 |
$1.66M |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
5,330 |
4,954 |
$1.53M |
| S9480 |
Intensive outpatient psychiatric services, per diem |
5,509 |
918 |
$1.53M |
| 36902 |
|
873 |
807 |
$1.53M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
9,633 |
8,250 |
$1.47M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
3,655 |
3,443 |
$1.45M |
| 93798 |
|
5,728 |
900 |
$1.44M |
| 96415 |
|
3,789 |
2,607 |
$1.42M |
| G0378 |
Hospital observation service, per hour |
20,511 |
14,211 |
$1.39M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
10,005 |
8,947 |
$1.38M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
6,306 |
5,858 |
$1.36M |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
3,323 |
2,616 |
$1.25M |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
6,487 |
6,179 |
$1.22M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
11,840 |
7,030 |
$1.19M |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
9,415 |
7,681 |
$1.15M |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
10,575 |
5,503 |
$1.11M |
| V5261 |
Hearing aid, digital, binaural, bte |
537 |
445 |
$1.09M |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
6,228 |
5,678 |
$1.08M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
7,254 |
5,633 |
$991K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
14,688 |
14,069 |
$991K |
| 93976 |
|
5,026 |
4,500 |
$984K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
5,405 |
5,042 |
$901K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
13,017 |
8,244 |
$895K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
8,723 |
7,824 |
$859K |
| 99205 |
Prolong outpt/office vis |
4,299 |
3,926 |
$805K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,356 |
1,258 |
$793K |
| 76642 |
|
5,577 |
5,241 |
$776K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
5,242 |
1,399 |
$723K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
3,838 |
3,625 |
$709K |
| 93970 |
|
4,122 |
3,821 |
$694K |
| 76830 |
Ultrasound, transvaginal |
6,193 |
5,894 |
$668K |
| 19083 |
|
532 |
465 |
$662K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
8,654 |
6,842 |
$656K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
3,027 |
2,809 |
$636K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
5,242 |
4,824 |
$621K |
| 71046 |
Radiologic examination, chest; 2 views |
37,372 |
34,508 |
$607K |
| 74183 |
|
1,692 |
1,577 |
$605K |
| 36821 |
|
217 |
200 |
$604K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,649 |
3,449 |
$580K |
| 64483 |
|
638 |
583 |
$571K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
3,412 |
3,167 |
$549K |
| J9355 |
Injection, trastuzumab, excludes biosimilar, 10 mg |
615 |
273 |
$546K |
| 93971 |
|
4,817 |
4,458 |
$540K |
| 72197 |
|
1,046 |
993 |
$530K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
1,434 |
1,121 |
$507K |
| 72141 |
|
2,600 |
2,430 |
$501K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,127 |
699 |
$495K |
| J0897 |
Injection, denosumab, 1 mg |
618 |
528 |
$470K |
| Q5118 |
Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg |
250 |
110 |
$450K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,943 |
3,640 |
$439K |
| 20550 |
|
1,165 |
998 |
$432K |
| 77386 |
|
657 |
66 |
$416K |
| 97165 |
|
3,046 |
2,711 |
$408K |
| 97161 |
|
4,035 |
3,608 |
$401K |
| 10060 |
|
1,451 |
1,365 |
$398K |
| 71250 |
|
5,200 |
4,831 |
$396K |
| 92557 |
|
4,900 |
4,371 |
$389K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
916 |
610 |
$373K |
| J2505 |
Injection, pegfilgrastim, 6 mg |
296 |
193 |
$372K |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
1,693 |
945 |
$372K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
1,513 |
1,348 |
$369K |
| 70491 |
|
1,592 |
1,486 |
$364K |
| 90791 |
Psychiatric diagnostic evaluation |
1,312 |
1,138 |
$360K |
| 93922 |
|
3,360 |
3,116 |
$357K |
| 78306 |
|
1,060 |
994 |
$353K |
| 76536 |
|
2,573 |
2,380 |
$351K |
| 93975 |
|
2,308 |
2,187 |
$351K |
| 77336 |
|
3,311 |
1,399 |
$337K |
| 92950 |
|
834 |
664 |
$329K |
| 96367 |
|
3,491 |
2,238 |
$327K |
| 77334 |
|
1,649 |
863 |
$311K |
| 74174 |
|
1,717 |
1,598 |
$308K |
| 73630 |
|
11,888 |
10,492 |
$304K |
| 70544 |
|
1,189 |
1,086 |
$304K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
78,841 |
56,388 |
$290K |
| 76770 |
|
2,181 |
2,027 |
$289K |
| 93925 |
|
1,985 |
1,829 |
$287K |
| 36561 |
|
128 |
114 |
$279K |
| 94660 |
|
1,008 |
623 |
$279K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
2,335 |
2,144 |
$276K |
| 90715 |
|
9,145 |
8,588 |
$274K |
| 92083 |
|
4,702 |
4,259 |
$272K |
| 31575 |
|
1,960 |
1,822 |
$264K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
7,680 |
6,968 |
$261K |
| J1453 |
Injection, fosaprepitant, 1 mg |
1,977 |
1,129 |
$246K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
1,616 |
1,045 |
$246K |
| 52000 |
|
270 |
253 |
$246K |
| 76801 |
|
2,385 |
2,108 |
$244K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,690 |
3,227 |
$230K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
3,194 |
2,051 |
$221K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
2,658 |
2,421 |
$218K |
| 31579 |
|
284 |
260 |
$213K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
5,663 |
4,615 |
$207K |
| 73562 |
|
8,704 |
7,743 |
$199K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
847 |
739 |
$195K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
49,094 |
43,208 |
$193K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
41,322 |
24,686 |
$192K |
| 77062 |
|
3,137 |
3,000 |
$188K |
| 12001 |
|
642 |
611 |
$181K |
| 94060 |
|
1,591 |
1,453 |
$179K |
| 70486 |
|
4,030 |
3,794 |
$177K |
| 96040 |
|
577 |
543 |
$175K |
| 73030 |
|
7,909 |
7,179 |
$170K |
| 92550 |
|
1,672 |
1,488 |
$166K |
| 80053 |
Comprehensive metabolic panel |
51,823 |
42,957 |
$159K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
4,679 |
4,352 |
$159K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
14,732 |
14,115 |
$159K |
| 93017 |
|
2,112 |
1,943 |
$157K |
| 72100 |
|
6,265 |
5,823 |
$156K |
| 77080 |
|
2,999 |
2,873 |
$152K |
| 90686 |
|
5,723 |
5,275 |
$149K |
| 73560 |
|
5,852 |
5,246 |
$142K |
| 70498 |
|
737 |
687 |
$137K |
| 71271 |
|
974 |
948 |
$132K |
| 69210 |
|
2,876 |
2,675 |
$131K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
16,595 |
15,156 |
$120K |
| 73610 |
|
7,797 |
6,728 |
$119K |
| 77470 |
|
273 |
230 |
$118K |
| Q3014 |
Telehealth originating site facility fee |
9,417 |
8,300 |
$118K |
| 75574 |
|
249 |
236 |
$117K |
| 94726 |
|
2,477 |
2,299 |
$117K |
| 97535 |
Self-care/home management training, each 15 minutes |
1,187 |
772 |
$116K |
| 77300 |
|
1,112 |
488 |
$111K |
| 73130 |
|
7,349 |
6,480 |
$107K |
| 73221 |
|
513 |
462 |
$106K |
| 93320 |
|
471 |
437 |
$104K |
| 97116 |
|
1,388 |
794 |
$103K |
| 93880 |
|
952 |
865 |
$102K |
| 70496 |
|
255 |
235 |
$100K |
| 88341 |
|
2,723 |
2,489 |
$99K |
| 92504 |
|
2,527 |
2,339 |
$97K |
| 76813 |
|
1,881 |
1,730 |
$96K |
| 83880 |
|
11,877 |
10,717 |
$94K |
| 77061 |
|
1,649 |
1,583 |
$92K |
| 93750 |
|
2,236 |
1,639 |
$90K |
| 94010 |
|
880 |
798 |
$90K |
| J9312 |
Injection, rituximab, 10 mg |
30 |
12 |
$87K |
| 72110 |
|
2,741 |
2,554 |
$86K |
| 73110 |
|
4,846 |
4,219 |
$85K |
| 77065 |
Tomosynthesis, mammo |
3,724 |
3,385 |
$83K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
57 |
49 |
$80K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,081 |
583 |
$79K |
| 72040 |
|
2,472 |
2,245 |
$77K |
| 20605 |
|
186 |
169 |
$77K |
| 73502 |
|
5,631 |
5,069 |
$76K |
| 62323 |
|
60 |
60 |
$76K |
| 72131 |
|
1,574 |
1,464 |
$75K |
| 90677 |
|
501 |
468 |
$75K |
| 93296 |
|
1,477 |
1,391 |
$72K |
| 93458 |
|
89 |
86 |
$72K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
845 |
785 |
$70K |
| 12011 |
|
325 |
303 |
$70K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
23,994 |
21,618 |
$69K |
| 73700 |
|
555 |
518 |
$69K |
| 71045 |
Radiologic examination, chest; single view |
15,377 |
13,628 |
$68K |
| J1750 |
Injection, iron dextran, 50 mg |
985 |
636 |
$68K |
| 77066 |
Tomosynthesis, mammo |
4,464 |
4,225 |
$66K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
26,341 |
18,356 |
$66K |
| 76820 |
|
1,771 |
940 |
$65K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
500 |
452 |
$63K |
| 86923 |
|
1,730 |
1,339 |
$62K |
| 51705 |
|
493 |
452 |
$61K |
| 12002 |
|
232 |
218 |
$60K |
| 93613 |
|
15 |
12 |
$60K |
| 92133 |
|
3,776 |
3,472 |
$58K |
| 92020 |
|
595 |
554 |
$58K |
| 49083 |
|
213 |
94 |
$55K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
257 |
229 |
$54K |
| V5020 |
Conformity evaluation |
1,399 |
1,083 |
$52K |
| 94729 |
|
2,469 |
2,293 |
$52K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
36,385 |
32,294 |
$51K |
| 75561 |
|
80 |
78 |
$51K |
| C1776 |
Joint device (implantable) |
293 |
262 |
$51K |
| 76000 |
|
2,780 |
2,538 |
$50K |
| 76821 |
|
1,591 |
843 |
$49K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14,973 |
13,837 |
$47K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
128 |
114 |
$47K |
| 73564 |
|
1,274 |
1,176 |
$47K |
| V5010 |
Assessment for hearing aid |
1,210 |
954 |
$46K |
| 90750 |
|
617 |
578 |
$45K |
| 29581 |
|
188 |
98 |
$44K |
| 88307 |
|
2,179 |
1,718 |
$44K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
126,830 |
92,001 |
$43K |
| 31231 |
|
214 |
209 |
$43K |
| 37607 |
|
84 |
77 |
$42K |
| 76512 |
|
341 |
302 |
$41K |
| 76775 |
|
293 |
276 |
$41K |
| V5011 |
Fitting/orientation/checking of hearing aid |
1,364 |
1,062 |
$41K |
| 43235 |
|
74 |
65 |
$41K |
| 84484 |
|
41,368 |
33,427 |
$41K |
| 92567 |
|
2,074 |
1,848 |
$40K |
| 36830 |
|
55 |
51 |
$40K |
| 95816 |
|
176 |
162 |
$40K |
| 16020 |
|
218 |
183 |
$38K |
| 74178 |
|
135 |
125 |
$38K |
| 72050 |
|
1,161 |
1,063 |
$38K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,299 |
1,191 |
$37K |
| 99201 |
|
263 |
229 |
$37K |
| 73120 |
|
761 |
684 |
$37K |
| 60100 |
|
43 |
40 |
$35K |
| 36832 |
|
14 |
12 |
$35K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
104 |
87 |
$35K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
160 |
156 |
$35K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
159 |
153 |
$34K |
| 93247 |
|
328 |
313 |
$32K |
| 76870 |
|
489 |
445 |
$32K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
324 |
304 |
$32K |
| 72070 |
|
1,519 |
1,405 |
$32K |
| 90670 |
|
815 |
743 |
$31K |
| 85379 |
|
6,139 |
5,730 |
$31K |
| 72146 |
|
449 |
426 |
$31K |
| 77049 |
|
52 |
51 |
$28K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
110 |
106 |
$27K |
| 73590 |
|
3,914 |
3,375 |
$27K |
| 77301 |
|
14 |
13 |
$27K |
| C9257 |
Injection, bevacizumab, 0.25 mg |
43 |
39 |
$26K |
| C1769 |
Guide wire |
8,011 |
7,137 |
$25K |
| 93926 |
|
364 |
340 |
$25K |
| 92136 |
|
711 |
641 |
$23K |
| 73080 |
|
2,333 |
2,100 |
$23K |
| 94618 |
|
130 |
112 |
$23K |
| 64493 |
|
29 |
28 |
$22K |
| 80076 |
|
10,812 |
8,899 |
$22K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
73 |
62 |
$21K |
| 77290 |
|
62 |
57 |
$21K |
| 87040 |
|
2,735 |
2,264 |
$21K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,399 |
1,245 |
$20K |
| 64454 |
|
31 |
25 |
$19K |
| 29125 |
|
86 |
83 |
$18K |
| 90656 |
|
734 |
713 |
$18K |
| 15275 |
|
16 |
13 |
$18K |
| 20553 |
|
50 |
47 |
$17K |
| 36901 |
|
13 |
12 |
$17K |
| V5275 |
Ear impression, each |
452 |
378 |
$17K |
| 76827 |
|
605 |
351 |
$17K |
| 83605 |
|
13,278 |
11,643 |
$16K |
| 86850 |
|
13,069 |
11,048 |
$16K |
| 76942 |
|
219 |
209 |
$16K |
| 77002 |
|
109 |
104 |
$16K |
| 90694 |
|
1,180 |
1,125 |
$16K |
| 86900 |
|
14,862 |
12,633 |
$16K |
| 73620 |
|
300 |
282 |
$16K |
| 74018 |
|
996 |
863 |
$15K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
3,625 |
3,280 |
$15K |
| 73552 |
|
2,349 |
2,106 |
$15K |
| 73522 |
|
406 |
380 |
$15K |
| 36247 |
|
17 |
13 |
$15K |
| 90836 |
|
136 |
127 |
$15K |
| 59020 |
|
56 |
55 |
$15K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,428 |
1,270 |
$15K |
| 73140 |
|
863 |
768 |
$14K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
2,735 |
2,433 |
$14K |
| 96401 |
|
717 |
316 |
$14K |
| 82962 |
|
51,473 |
33,460 |
$14K |
| 77280 |
|
98 |
83 |
$14K |
| V5264 |
Ear mold/insert, not disposable, any type |
223 |
188 |
$13K |
| 90732 |
|
889 |
823 |
$13K |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
82 |
67 |
$13K |
| 96416 |
|
182 |
99 |
$13K |
| 31720 |
|
1,052 |
946 |
$13K |
| 72170 |
|
1,373 |
1,271 |
$12K |
| 77001 |
|
152 |
139 |
$12K |
| 73060 |
|
1,613 |
1,413 |
$12K |
| 95819 |
|
58 |
53 |
$12K |
| 90837 |
Psychotherapy, 53 minutes with patient |
112 |
54 |
$12K |
| 96376 |
|
14,414 |
8,277 |
$12K |
| 99218 |
|
176 |
147 |
$12K |
| 76937 |
|
318 |
278 |
$12K |
| 80320 |
|
4,005 |
3,550 |
$12K |
| 29515 |
|
47 |
47 |
$12K |
| 92570 |
|
1,928 |
1,754 |
$11K |
| 83735 |
|
31,483 |
19,654 |
$11K |
| A4648 |
Tissue marker, implantable, any type, each |
1,025 |
896 |
$11K |
| 73521 |
|
596 |
552 |
$11K |
| 90834 |
Psychotherapy, 45 minutes with patient |
83 |
55 |
$10K |
| 77338 |
|
27 |
25 |
$10K |
| 93298 |
|
221 |
194 |
$10K |
| 76641 |
|
53 |
50 |
$10K |
| 85027 |
|
6,545 |
4,807 |
$10K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
27 |
27 |
$10K |
| 93460 |
|
19 |
17 |
$10K |
| 70547 |
|
145 |
129 |
$9K |
| 93325 |
|
421 |
391 |
$9K |
| 78582 |
|
49 |
48 |
$9K |
| 96368 |
|
1,027 |
674 |
$9K |
| 36590 |
|
12 |
12 |
$9K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,124 |
7,381 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
8,918 |
7,924 |
$9K |
| 88312 |
|
5,348 |
4,942 |
$8K |
| 77295 |
|
17 |
13 |
$8K |
| 97802 |
|
59 |
24 |
$8K |
| 97597 |
|
40 |
26 |
$8K |
| 36905 |
|
14 |
13 |
$8K |
| 92587 |
|
74 |
70 |
$8K |
| 93923 |
|
33 |
32 |
$8K |
| 72192 |
|
41 |
40 |
$8K |
| 72128 |
|
522 |
480 |
$8K |
| 92082 |
|
70 |
68 |
$8K |
| 88304 |
|
1,383 |
1,218 |
$8K |
| 73600 |
|
200 |
165 |
$7K |
| 95913 |
|
55 |
51 |
$7K |
| 81001 |
|
35,369 |
31,950 |
$7K |
| 51702 |
|
701 |
634 |
$7K |
| 73090 |
|
1,741 |
1,553 |
$7K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,808 |
1,778 |
$7K |
| 92134 |
|
4,496 |
3,903 |
$7K |
| 82803 |
|
7,285 |
6,593 |
$7K |
| J3489 |
Injection, zoledronic acid, 1 mg |
112 |
106 |
$7K |
| 80061 |
Lipid panel |
3,319 |
2,907 |
$7K |
| 88342 |
|
3,825 |
3,073 |
$7K |
| 76514 |
|
405 |
367 |
$7K |
| 88313 |
|
761 |
653 |
$7K |
| 86901 |
|
14,873 |
12,632 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
9,005 |
8,007 |
$6K |
| 64484 |
|
164 |
150 |
$6K |
| J7325 |
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg |
41 |
40 |
$6K |
| 91322 |
|
190 |
189 |
$6K |
| 96523 |
|
145 |
93 |
$6K |
| 82375 |
|
7,316 |
6,619 |
$6K |
| 85610 |
|
24,593 |
18,592 |
$5K |
| C1768 |
Graft, vascular |
76 |
69 |
$5K |
| 95886 |
|
31 |
29 |
$5K |
| 99385 |
|
30 |
26 |
$5K |
| 74220 |
|
102 |
97 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
8,466 |
7,393 |
$5K |
| 99386 |
|
44 |
39 |
$5K |
| 90688 |
|
260 |
244 |
$5K |
| 90838 |
|
47 |
45 |
$5K |
| 90832 |
Psychotherapy, 30 minutes with patient |
60 |
41 |
$5K |
| 11104 |
|
13 |
12 |
$4K |
| 51798 |
|
1,481 |
1,390 |
$4K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
14 |
14 |
$4K |
| 90662 |
|
230 |
225 |
$4K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
2,274 |
2,180 |
$4K |
| 36430 |
|
33 |
24 |
$4K |
| 92593 |
|
178 |
116 |
$4K |
| C1760 |
Closure device, vascular (implantable/insertable) |
1,750 |
1,556 |
$4K |
| J3490 |
Unclassified drugs |
14,037 |
7,905 |
$4K |
| 84100 |
|
15,389 |
8,212 |
$4K |
| 70487 |
|
13 |
12 |
$3K |
| 86317 |
|
928 |
810 |
$3K |
| 96417 |
|
3,197 |
1,906 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
26,984 |
23,447 |
$3K |
| 88185 |
|
92 |
78 |
$3K |
| 92511 |
|
13 |
13 |
$3K |
| 74181 |
|
14 |
14 |
$3K |
| 84703 |
|
13,033 |
12,120 |
$3K |
| 51700 |
|
24 |
24 |
$3K |
| 92591 |
|
123 |
83 |
$3K |
| 83690 |
|
23,319 |
21,077 |
$3K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
94 |
91 |
$3K |
| 90651 |
|
20 |
18 |
$3K |
| C2623 |
Catheter, transluminal angioplasty, drug-coated, non-laser |
14 |
14 |
$3K |
| 87581 |
|
492 |
447 |
$3K |
| 70480 |
|
14 |
12 |
$2K |
| 82570 |
|
1,624 |
1,373 |
$2K |
| 80329 |
|
114 |
108 |
$2K |
| 71101 |
|
488 |
456 |
$2K |
| 83615 |
|
3,351 |
2,346 |
$2K |
| 84702 |
|
6,943 |
5,623 |
$2K |
| 90746 |
|
128 |
123 |
$2K |
| 82330 |
|
3,531 |
2,429 |
$2K |
| 81025 |
|
16,944 |
15,743 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,518 |
1,362 |
$2K |
| 74240 |
|
12 |
12 |
$2K |
| 90653 |
|
892 |
801 |
$2K |
| 74022 |
|
586 |
547 |
$2K |
| 93246 |
|
35 |
32 |
$2K |
| C1874 |
Stent, coated/covered, with delivery system |
42 |
40 |
$2K |
| 86592 |
|
1,083 |
990 |
$2K |
| 87077 |
|
3,406 |
3,130 |
$2K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
61 |
42 |
$2K |
| 74230 |
|
26 |
25 |
$2K |
| 92588 |
|
27 |
24 |
$2K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
4,136 |
3,694 |
$2K |
| 36591 |
|
288 |
191 |
$2K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
86 |
86 |
$2K |
| 81003 |
|
14,958 |
13,915 |
$2K |
| 75635 |
|
12 |
12 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
34,983 |
27,265 |
$1K |
| 86141 |
|
2,406 |
2,090 |
$1K |
| G0379 |
Direct admission of patient for hospital observation care |
58 |
53 |
$1K |
| 72158 |
|
12 |
12 |
$1K |
| 80164 |
|
312 |
270 |
$1K |
| 77417 |
|
726 |
387 |
$1K |
| 85730 |
|
4,031 |
3,259 |
$1K |
| 73100 |
|
39 |
36 |
$1K |
| 84439 |
|
1,654 |
1,435 |
$1K |
| 90658 |
|
75 |
72 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,696 |
3,481 |
$1K |
| 92002 |
|
12 |
12 |
$1K |
| 80185 |
|
140 |
112 |
$1K |
| 76882 |
|
13 |
12 |
$1K |
| 82607 |
|
1,285 |
1,145 |
$1K |
| 73070 |
|
12 |
12 |
$1K |
| 73200 |
|
14 |
12 |
$1K |
| 82728 |
|
1,232 |
1,047 |
$1K |
| 84550 |
|
1,951 |
1,549 |
$1K |
| 92611 |
|
44 |
38 |
$965.63 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
26,680 |
23,422 |
$930.28 |
| 99152 |
|
1,795 |
1,599 |
$929.84 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
528 |
477 |
$866.20 |
| 90678 |
|
14 |
14 |
$855.06 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
471 |
445 |
$840.44 |
| 46600 |
|
603 |
551 |
$834.29 |
| 88184 |
|
97 |
78 |
$827.47 |
| 80050 |
General health panel |
66 |
55 |
$825.38 |
| 96402 |
|
706 |
295 |
$823.96 |
| 87070 |
|
3,012 |
2,611 |
$815.10 |
| 84156 |
|
1,270 |
1,039 |
$753.40 |
| 90739 |
|
28 |
24 |
$748.71 |
| 87081 |
|
268 |
236 |
$712.78 |
| 93282 |
|
54 |
50 |
$693.96 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
4,102 |
3,781 |
$690.56 |
| 87186 |
|
3,255 |
3,014 |
$686.14 |
| 74019 |
|
47 |
38 |
$685.78 |
| 70490 |
|
18 |
14 |
$683.27 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
469 |
416 |
$679.99 |
| 82550 |
|
2,158 |
1,781 |
$656.46 |
| 88172 |
|
1,010 |
939 |
$649.70 |
| 97166 |
|
12 |
12 |
$649.28 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
683 |
623 |
$641.86 |
| 93350 |
|
70 |
63 |
$641.76 |
| G0008 |
Administration of influenza virus vaccine |
3,001 |
2,817 |
$619.91 |
| 92555 |
|
50 |
39 |
$618.92 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
29 |
29 |
$579.10 |
| 0352U |
|
16 |
14 |
$554.70 |
| 82947 |
|
5,501 |
4,940 |
$539.63 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
11,864 |
9,982 |
$506.32 |
| 89051 |
|
425 |
275 |
$501.03 |
| 0124A |
|
13 |
13 |
$466.40 |
| 85652 |
|
2,643 |
2,368 |
$464.86 |
| 92132 |
|
17 |
16 |
$448.62 |
| 87486 |
|
175 |
169 |
$441.28 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
405 |
370 |
$440.86 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
777 |
688 |
$433.98 |
| 70355 |
|
485 |
434 |
$414.86 |
| 87340 |
|
1,167 |
1,013 |
$405.29 |
| 86360 |
|
37 |
31 |
$373.19 |
| 93280 |
|
28 |
26 |
$349.12 |
| 51703 |
|
49 |
49 |
$348.36 |
| 82077 |
|
3,792 |
3,390 |
$339.63 |
| 96409 |
|
216 |
105 |
$329.42 |
| 80047 |
|
41 |
37 |
$321.50 |
| 82270 |
|
1,173 |
1,081 |
$309.26 |
| 90480 |
|
194 |
189 |
$304.02 |
| 87899 |
|
369 |
334 |
$298.32 |
| 83540 |
|
847 |
752 |
$275.45 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
912 |
868 |
$275.40 |
| 87075 |
|
1,586 |
1,271 |
$239.55 |
| 84132 |
|
2,415 |
2,144 |
$236.82 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
9,858 |
7,159 |
$226.93 |
| 82248 |
|
923 |
614 |
$226.19 |
| 82746 |
|
522 |
470 |
$215.10 |
| 82010 |
|
586 |
528 |
$215.03 |
| 87205 |
|
2,358 |
1,987 |
$211.05 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
113 |
110 |
$208.19 |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,181 |
1,102 |
$200.83 |
| 83550 |
|
574 |
516 |
$195.26 |
| 82820 |
|
2,221 |
1,977 |
$195.23 |
| 94762 |
|
749 |
643 |
$187.26 |
| 87428 |
|
390 |
383 |
$176.93 |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,553 |
1,284 |
$175.92 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
1,259 |
1,172 |
$166.65 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,638 |
4,947 |
$164.90 |
| C1750 |
Catheter, hemodialysis/peritoneal, long-term |
62 |
52 |
$159.94 |
| 88360 |
|
16 |
15 |
$155.19 |
| 91065 |
|
12 |
12 |
$150.67 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
11,299 |
3,744 |
$150.54 |
| 88112 |
|
103 |
98 |
$149.14 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
23,516 |
17,705 |
$146.76 |
| 85045 |
|
572 |
440 |
$142.41 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
16 |
16 |
$140.44 |
| 94760 |
|
1,635 |
1,108 |
$134.28 |
| 87147 |
|
318 |
295 |
$132.70 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
1,065 |
881 |
$114.14 |
| 82565 |
|
102 |
100 |
$106.48 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
8,751 |
4,775 |
$104.98 |
| 84295 |
|
2,187 |
1,940 |
$104.92 |
| 87480 |
|
39 |
39 |
$101.32 |
| 86870 |
|
28 |
24 |
$99.16 |
| J1644 |
Injection, heparin sodium, per 1000 units |
20,797 |
9,933 |
$94.35 |
| C1733 |
Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, other than cool-tip |
309 |
268 |
$89.11 |
| 81002 |
|
1,113 |
1,033 |
$87.69 |
| 99153 |
Mod sedat endo service >5yrs |
690 |
610 |
$87.63 |
| J2704 |
Injection, propofol, 10 mg |
27,846 |
25,488 |
$82.41 |
| 88311 |
|
136 |
122 |
$78.14 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
9,060 |
6,669 |
$71.08 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
473 |
459 |
$67.20 |
| 88173 |
|
1,081 |
1,007 |
$57.04 |
| 87510 |
|
39 |
39 |
$54.44 |
| 86140 |
|
299 |
274 |
$53.98 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
30 |
29 |
$53.20 |
| 85014 |
|
341 |
302 |
$49.50 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
7,817 |
5,224 |
$48.43 |
| J3411 |
Injection, thiamine hcl, 100 mg |
2,152 |
1,616 |
$47.95 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
2,102 |
1,642 |
$47.49 |
| 87660 |
|
39 |
39 |
$46.88 |
| 84520 |
|
99 |
97 |
$41.46 |
| 80074 |
|
61 |
54 |
$40.22 |
| J7799 |
Noc drugs, other than inhalation drugs, administered through dme |
1,444 |
1,100 |
$39.51 |
| 88302 |
|
80 |
74 |
$34.86 |
| 82436 |
|
46 |
41 |
$34.80 |
| J7050 |
Infusion, normal saline solution, 250 cc |
10,151 |
6,192 |
$32.49 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
22,368 |
20,152 |
$29.87 |
| J1940 |
Injection, furosemide, up to 20 mg |
3,800 |
2,117 |
$28.92 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
144 |
128 |
$27.25 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
19,063 |
13,034 |
$23.82 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
4,014 |
3,126 |
$21.53 |
| 84133 |
|
45 |
40 |
$20.86 |
| 84300 |
|
88 |
79 |
$20.69 |
| 88108 |
|
38 |
37 |
$20.43 |
| 85384 |
|
16 |
13 |
$16.53 |
| C9399 |
Unclassified drugs or biologicals |
4,425 |
4,038 |
$16.52 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
2,076 |
1,081 |
$16.28 |
| J7999 |
Compounded drug, not otherwise classified |
4,625 |
4,176 |
$16.28 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
2,944 |
2,587 |
$15.27 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,859 |
1,546 |
$14.83 |
| J2060 |
Injection, lorazepam, 2 mg |
3,241 |
2,570 |
$14.42 |
| 82150 |
|
13 |
12 |
$14.11 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,989 |
1,775 |
$11.81 |
| 87280 |
|
61 |
59 |
$11.81 |
| J1790 |
Injection, droperidol, up to 5 mg |
2,800 |
2,587 |
$10.30 |
| 87015 |
|
103 |
66 |
$10.13 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
4,656 |
3,261 |
$9.40 |
| 85008 |
|
19 |
15 |
$8.78 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
4,657 |
4,221 |
$5.34 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
2,704 |
1,683 |
$4.88 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
4,175 |
3,550 |
$2.90 |
| C9113 |
Injection, pantoprazole sodium, per vial |
1,946 |
966 |
$2.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,423 |
1,252 |
$1.53 |
| J9190 |
Injection, fluorouracil, 500 mg |
360 |
195 |
$1.27 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,316 |
1,190 |
$1.05 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
5,684 |
5,133 |
$1.05 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,001 |
861 |
$0.96 |
| J0456 |
Injection, azithromycin, 500 mg |
540 |
368 |
$0.65 |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,792 |
1,256 |
$0.49 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,330 |
1,208 |
$0.26 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
1,583 |
1,270 |
$0.08 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
2,011 |
1,809 |
$0.00 |
| C1758 |
Catheter, ureteral |
487 |
445 |
$0.00 |
| C1729 |
Catheter, drainage |
445 |
385 |
$0.00 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
2,497 |
1,485 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
580 |
485 |
$0.00 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
150 |
112 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
809 |
700 |
$0.00 |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
113 |
59 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
799 |
669 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
349 |
272 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
999 |
898 |
$0.00 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
213 |
124 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
227 |
204 |
$0.00 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
146 |
141 |
$0.00 |
| 0272 |
|
482 |
436 |
$0.00 |
| 64495 |
|
29 |
28 |
$0.00 |
| J3371 |
Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg |
87 |
76 |
$0.00 |
| C1757 |
Catheter, thrombectomy/embolectomy |
123 |
106 |
$0.00 |
| C1788 |
Port, indwelling (implantable) |
100 |
89 |
$0.00 |
| G8989 |
Self care functional limitation, discharge status, at discharge from therapy or to end reporting |
384 |
342 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
732 |
707 |
$0.00 |
| 82805 |
|
123 |
112 |
$0.00 |
| 87102 |
|
47 |
38 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,219 |
1,111 |
$0.00 |
| 51701 |
|
31 |
25 |
$0.00 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
92 |
62 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
57 |
57 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
249 |
240 |
$0.00 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
12 |
12 |
$0.00 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
14 |
12 |
$0.00 |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
107 |
26 |
$0.00 |
| 80143 |
|
17 |
15 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
106 |
74 |
$0.00 |
| 93356 |
|
14 |
14 |
$0.00 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
60 |
36 |
$0.00 |
| 80179 |
|
15 |
14 |
$0.00 |
| J0670 |
Injection, mepivacaine hydrochloride, per 10 ml |
15 |
12 |
$0.00 |
| J3260 |
Injection, tobramycin sulfate, up to 80 mg |
13 |
13 |
$0.00 |
| C1766 |
Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away |
668 |
604 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
620 |
567 |
$0.00 |
| 0270 |
|
196 |
176 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
676 |
565 |
$0.00 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
126 |
93 |
$0.00 |
| J9045 |
Injection, carboplatin, 50 mg |
673 |
393 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
37 |
30 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
749 |
441 |
$0.00 |
| 96411 |
|
593 |
373 |
$0.00 |
| C1819 |
Surgical tissue localization and excision device (implantable) |
420 |
379 |
$0.00 |
| J0610 |
Injection, calcium gluconate (fresenius kabi), per 10 ml |
309 |
221 |
$0.00 |
| 0250 |
|
1,359 |
784 |
$0.00 |
| 0370 |
|
349 |
347 |
$0.00 |
| V2632 |
Posterior chamber intraocular lens |
454 |
362 |
$0.00 |
| 0721 |
|
192 |
164 |
$0.00 |
| C1773 |
Retrieval device, insertable (used to retrieve fractured medical devices) |
310 |
292 |
$0.00 |
| 0710 |
|
333 |
329 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
632 |
526 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
427 |
384 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
275 |
272 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
622 |
571 |
$0.00 |
| C1781 |
Mesh (implantable) |
27 |
25 |
$0.00 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
180 |
102 |
$0.00 |
| J9267 |
Injection, paclitaxel, 1 mg |
477 |
216 |
$0.00 |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
28 |
17 |
$0.00 |
| C1892 |
Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away |
16 |
13 |
$0.00 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
57 |
53 |
$0.00 |
| A9558 |
Xenon xe-133 gas, diagnostic, per 10 millicuries |
41 |
41 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
213 |
205 |
$0.00 |
| A9540 |
Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries |
60 |
58 |
$0.00 |
| C1732 |
Catheter, electrophysiology, diagnostic/ablation, 3d or vector mapping |
15 |
12 |
$0.00 |
| 64494 |
|
29 |
28 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
17 |
16 |
$0.00 |
| 96377 |
|
34 |
27 |
$0.00 |
| C1730 |
Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes) |
16 |
13 |
$0.00 |
| 88300 |
|
17 |
15 |
$0.00 |
| J2373 |
Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms |
19 |
18 |
$0.00 |